AARTIPHARM.BOAARTIPHARM.BOBSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+80.3%
5Y CAGR+513.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+80.3%/yr
Annual compound
5Y CAGR
+513.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
8672.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$1.62B+101.5%
2024$803.59M-32.1%
2023$1.18B+327.8%
2022$276.45M+601397.0%
2021$45960.00-75.4%
2020$186751.00-